Valproic acid effects in the hippocampus and prefrontal cortex in an animal model of post-traumatic stress disorder

Behavioural Brain Research

Volumn 268, Issue , 2014, Pages 72-80

  Wilson, C Brad ^a   McLaughlin, Leslie D ^a   Ebenezer, Philip J ^a   Nair, Anand R ^a   Francis, Joseph ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Anxiety; HDAC; Inflammation; Norepinephrine; PTSD; Serotonin

Indexed keywords

ANXIOLYTIC AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NORADRENALIN; SEROTONIN; VALPROIC ACID;

ANIMAL; ANXIETY; CAT; DISEASE MODEL; DRUG EFFECTS; DRUG THERAPY; FEAR; HIPPOCAMPUS; IMMUNOMODULATION; MALE; MAZE TEST; METABOLISM; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDATION; PREFRONTAL CORTEX; REINFORCEMENT; SPRAGUE DAWLEY RAT; STRESS DISORDERS, POST-TRAUMATIC;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; CATS; DISEASE MODELS, ANIMAL; EXTINCTION, PSYCHOLOGICAL; FEAR; HIPPOCAMPUS; MALE; MAZE LEARNING; NEUROIMMUNOMODULATION; NF-KAPPA B; NOREPINEPHRINE; OXIDATIVE STRESS; PREDATORY BEHAVIOR; PREFRONTAL CORTEX; RATS, SPRAGUE-DAWLEY; SEROTONIN; STRESS DISORDERS, POST-TRAUMATIC; VALPROIC ACID;

EID: 84898985836     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.03.029     Document Type: Article

References (70)

1. Yehuda R. Post-traumatic stress disorder. N Engl J Med 2002, 346(2):108-114.
2. American P.A. Diagnostic and statistical manual of mental disorders: DSM-5 2013, APA, Washington, DC. 5th ed.
3. Oosthuizen F., Wegener G., Harvey B.H. Nitric oxide as inflammatory mediator in post-traumatic stress disorder (PTSD): evidence from an animal model. Neuropsychiatr Dis Treat 2005, 1(2):109-123.
4. Liberzon I., Abelson J.L., Flagel S.B., Raz J., Young E.A. Neuroendocrine and psychophysiologic responses in PTSD: a symptom provocation study. Neuropsychopharmacology 1999, 21(1):40-50.
5. Sondergaard H.P., Hansson L.O., Theorell T. The inflammatory markers C-reactive protein and serum amyloid A in refugees with and without posttraumatic stress disorder. Clin Chim Acta 2004, 342(1-2):93-98.
6. Wilson C.B., Ebenezer P.J., McLaughlin L.D., Francis J. Predator exposure/psychosocial stress animal model of post-traumatic stress disorder modulates neurotransmitters in the rat hippocampus and prefrontal cortex. PLoS One 2014, 9(2):e89104. 10.1371/journal.pone.0089104.
7. Cardinale J.P., Sriramula S., Pariaut R., Guggilam A., Mariappan N., Elks C.M., et al. HDAC inhibition attenuates inflammatory: hypertrophic, and hypertensive responses in spontaneously hypertensive rats. Hypertension 2010, 56(3):437-444.
8. Guggilam A., Cardinale J.P., Mariappan N., Sriramula S., Haque M., Francis J. Central TNF inhibition results in attenuated neurohumoral excitation in heart failure: a role for superoxide and nitric oxide. Basic Res Cardiol 2011, 106(2):273-286.
9. Elks C.M., Francis J. Central adiposity, systemic inflammation, and the metabolic syndrome. Curr Hypertens Rep 2010, 12(2):99-104.
10. Wilson C.B., McLaughlin L.D., Nair A., Ebenezer P.J., Dange R., Francis J. Inflammation and Oxidative Stress Are Elevated in the Brain, Blood, and Adrenal Glands during the Progression of Post-Traumatic Stress Disorder in a Predator Exposure Animal Model. PLoS One 2013, 8(10):e76146.
11. de Ruijter A.J., van Gennip A.H., Caron H.N., Kemp S., van Kuilenburg A.B. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 2003, 370(Pt 3):737-749.
12. Keslacy S., Tliba O., Baidouri H., Amrani Y. Inhibition of tumor necrosis factor-alpha-inducible inflammatory genes by interferon-gamma is associated with altered nuclear factor-kappaB transactivation and enhanced histone deacetylase activity. Mol Pharmacol 2007, 71(2):609-618.
13. Nair A.R., Boersma L.J., Schlitz L., Chaudhry M.A., Muschel R.J. Paradoxical effects of trichostatin A: inhibition of NF-Y-associated histone acetyltransferase activity, phosphorylation of hGCN5 and downregulation of cyclin A and B1 mRNA. Cancer Lett 2001, 166(1):55-64.
14. Tong X., Yin L., Giardina C. Butyrate suppresses Cox-2 activation in colon cancer cells through HDAC inhibition. Biochem Biophys Res Commun 2004, 317(2):463-471.
15. Sharma R.P., Grayson D.R., Gavin D.P. Histone deactylase 1 expression is increased in the prefrontal cortex of schizophrenia subjects: analysis of the National Brain Databank microarray collection. Schizophr Res 2008, 98(1-3):111-117.
16. Akiba Y., Cave J.W., Akiba N., Langley B., Ratan R.R., Baker H. Histone deacetylase inhibitors de-repress tyrosine hydroxylase expression in the olfactory bulb and rostral migratory stream. Biochem Biophys Res Commun 2010, 393(4):673-677.
17. Covington H.E., Maze I., LaPlant Q.C., Vialu V.F., Ohnshi Y.N., Berton O., et al. Antidepressant actions of histone deacetylase inhibitors. J Neurosci 2009, 29(37):11451-11460.
18. Alvarez-Breckenridge C.A., Yu J., Price R., Wei M., Wang Y., Nowicki M.O., et al. The histone deacetylase inhibitor valproic acid lessens NK cell action against oncolytic virus-infected glioblastoma cells by inhibition of STAT5/T-BET signaling and generation of gamma interferon. J Virol 2012, 86(8):4566-4577.
19. Morris M.J., Karra A.S., Monteggia L.M. Histone deacetylases govern cellular mechanisms underlying behavioral and synaptic plasticity in the developing and adult brain. Behav Pharmacol 2010, 21(5-6):409-419.
20. Malvaez M., Sanchis-Segura C., Vo D., Lattal K.M., Wood M.A. Modulation of chromatin modification facilitates extinction of cocaine-induced conditioned place preference. Biol Psychiatry 2010, 67(1):36-43.
21. Heinrichs S.C.et al. Repeated valproate treatment facilitates fear extinction under specific stimulus conditions. Neurosci Lett 2013.
22. Zoladz P.R., Conrad C.D., Fleshner M., Diamond D.M. Acute episodes of predator exposure in conjunction with chronic social instability as an animal model of post-traumatic stress disorder. Stress 2008, 11(4):259-281.
23. Zoladz P.R., Fleshner M., Diamond D.M. Psychosocial animal model of PTSD produces a long-lasting traumatic memory: an increase in general anxiety and PTSD-like glucocorticoid abnormalities. Psychoneuroendocrinology 2012, 37(9):1531-1545.
24. Agarwal D., Welsch M.A., Keller J.N., Francis J. Chronic exercise modulates RAS components and improves balance between pro- and anti-inflammatory cytokines in the brain of SHR. Basic Res Cardiol 2011, 106(6):1069-1085.
25. Deyama S., Katayama T., Ohno A., Nakagawa T., Kaneko S., Yamaguchi T., et al. Activation of the beta-adrenoceptor-protein kinase A signaling pathway within the ventral bed nucleus of the stria terminalis mediates the negative affective component of pain in rats. J Neurosci 2008, 28(31):7728-7736.
26. Daskalakis N.P., Yehuda R., Diamond D.M. Animal models in translational studies of PTSD. Psychoneuroendocrinology 2013, 38(9):1895-1911.
27. Brewin C.R., Andrews B., Valentine J.D. Meta-analysis of risk factors for posttraumatic stress disorder in trauma-exposed adults. J Consult Clin Psychol 2000, 68(5):748-766.
28. Nemeroff C.B., Bremner J.D., Foa E.B., Mayberg H.S., North C.S., Stein M.B. Posttraumatic stress disorder: a state-of-the-science review. J Psychiatr Res 2006, 40(1):1-21.
29. Halili M.A., Andrews M.R., Sweet M.J., Fairlie D.P. Histone deacetylase inhibitors in inflammatory disease. Curr Top Med Chem 2009, 9(3):309-319.
30. Kim H.J., Rowe M., Ren M., Hong J.S., Chen P.S., Chuang D.M. Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. J Pharmacol Exp Ther 2007, 321(3):892-901.
31. Aung H.T., Schroder K., Himes S.R., Brion K., van Zuylen W., Tricu A., et al. LPS regulates proinflammatory gene expression in macrophages by altering histone deacetylase expression. FASEB J 2006, 20(9):1315-1327.
32. Kim M.S., Kwon H.J., Lee Y.M., Baek J.H., Jang J.E., Lee S.W., et al. Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat Med 2001, 7(4):437-443.
33. Kazantsev A.G., Thompson L.M. Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. Nat Rev Drug Discov 2008, 7(10):854-868.
34. Pall M.L., Satterlee J.D. Elevated nitric oxide/peroxynitrite mechanism for the common etiology of multiple chemical sensitivity, chronic fatigue syndrome, and posttraumatic stress disorder. Ann N Y Acad Sci 2001, 933:323-329.
35. Alexopoulos G.S.et al. Functional connectivity in apathy of late-life depression: A preliminary study. J Affect Disord 2012.
36. Reuter S., Gupta S.C., Chaturvedi M.M., Aggarwal B.B. Oxidative stress, inflammation, and cancer: how are they linked?. Free Radic Biol Med 2010, 49(11):1603-1616.
37. McCann S.M., Kimura M., Karanth S., Yu W., Mastronardi C.A., Rettori V. The mechanism of action of cytokines to control the release of hypothalamic and pituitary hormones in infection. Ann N Y Acad Sci 2000, 917:4-18.
38. Chrousos G.P. The stress response and immune function: clinical implications. The 1999 Novera H. Spector Lecture. Ann N Y Acad Sci 2000, 917:38-67.
39. Dunn A.J. Cytokine activation of the HPA axis. Ann N Y Acad Sci 2000, 917:608-617.
40. Turnbull A.V., Lee S., Rivier C. Mechanisms of hypothalamic-pituitary-adrenal axis stimulation by immune signals in the adult rat. Ann N Y Acad Sci 1998, 840:434-443.
41. Chrousos G.P. Stress, chronic inflammation, and emotional and physical well-being: concurrent effects and chronic sequelae. J Allergy Clin Immunol 2000, 106(5 Suppl):S275-S291.
42. Diehl L.A., Alvares L.O., Noschang C., Eagelke D., Andreazza A.C., Goncalves C.A., et al. Long-lasting effects of maternal separation on an animal model of post-traumatic stress disorder: effects on memory and hippocampal oxidative stress. Neurochem Res 2012, 37(4):700-707.
43. Yazdi A.S., Drexler S.K., Tschopp J. The role of the inflammasome in nonmyeloid cells. J Clin Immunol 2010, 30(5):623-627.
44. Diamond D.M., Park C.R., Heman K.L., Rose G.M. Exposing rats to a predator impairs spatial working memory in the radial arm water maze. Hippocampus 1999, 9(5):542-552.
45. Montgomery K.C. The relation between fear induced by novel stimulation and exploratory behavior. J Comp Physiol Psychol 1955, 48(4):254-260.
46. Korte S.M., De Boer S.F. A robust animal model of state anxiety: fear-potentiated behaviour in the elevated plus-maze. Eur J Pharmacol 2003, 463(1-3):163-175.
47. Pellow S., Chopin P., File S.E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 1985, 14(3):149-167.
48. Arora R.C., Fichtner C.G., O'Connor F., Crayton J.W. Paroxetine binding in the blood platelets of post-traumatic stress disorder patients. Life Sci 1993, 53(11):919-928.
49. Geracioti T.D., Jefferson-Wilson L., Strawn J.R., Baker D.G., Dashevsky B.A., Horn P.S., et al. Effect of traumatic imagery on cerebrospinal fluid dopamine and serotonin metabolites in posttraumatic stress disorder. J Psychiatr Res 2013, 47(7):995-998.
50. Geracioti T.D., Baker D.G., Ekhator N.N., West S.A., Hill S.A., Bruce K.K., et al. CSF norepinephrine concentrations in posttraumatic stress disorder. Am J Psychiatry 2001, 158(8):1227-1230.
51. Yehuda R., Southwick S., Giller E.L., Ma X., Mason J.W. Urinary catecholamine excretion and severity of PTSD symptoms in Vietnam combat veterans. J Nerv Ment Dis 1992, 180(5):321-325.
52. Diamond D.M., Campbell A.M., Park C.R., Halonen J., Zoladz P.R. The temporal dynamics model of emotional memory processing: a synthesis on the neurobiological basis of stress-induced amnesia, flashbulb and traumatic memories, and the Yerkes-Dodson law. Neural Plast 2007, 2007:60803.
53. Berumen L.C., Rodriguez A., Miledi R., Garcia-Alcocer G. Serotonin receptors in hippocampus. Sci World J 2012, 2012:823493.
54. McEwen B.S., Weiss J.M., Schwartz L.S. Uptake of corticosterone by rat brain and its concentration by certain limbic structures. Brain Res 1969, 16(1):227-241.
55. Joca S.R., Ferreira F.R., Guimaraes F.S. Modulation of stress consequences by hippocampal monoaminergic: glutamatergic and nitrergic neurotransmitter systems. Stress 2007, 10(3):227-249.
56. Jurgens C.W., Rau K.E., Knudson C.A., King J.D., Carr P.A., Porter J.E., et al. Beta1 adrenergic receptor-mediated enhancement of hippocampal CA3 network activity. J Pharmacol Exp Ther 2005, 314(2):552-560.
57. Southwick S.M., Paige S., Morgan C.A., Bremner J.D., Krystal J.H., Charney D.S. Neurotransmitter alterations in PTSD: catecholamines and serotonin. Semin Clin Neuropsychiatry 1999, 4(4):242-248.
58. Zoladz P.R., Fleshner M., Diamond D.M. Differential effectiveness of tianeptine, clonidine and amitriptyline in blocking traumatic memory expression, anxiety and hypertension in an animal model of PTSD. Prog Neuropsychopharmacol Biol Psychiatry 2013, 44:1-16.
59. Cabib S., Puglisi-Allegra S. The mesoaccumbens dopamine in coping with stress. Neurosci Biobehav Rev 2012, 36(1):79-89.
60. Fisher P.M., Price J.C., Meltzer C.C., Moses Kolko E.L., Becker C., Berga S.L., et al. Medial prefrontal cortex serotonin 1A and 2A receptor binding interacts to predict threat-related amygdala reactivity. Biol Mood Anxiety Disord 2011, 1(1):2.
61. Finlay J.M., Zigmond M.J., Abercrombie E.D. Increased dopamine and norepinephrine release in medial prefrontal cortex induced by acute and chronic stress: effects of diazepam. Neuroscience 1995, 64(3):619-628.
62. Zhang Z., Cordeiro Matos S., Jego S., Adamantidis A., Seguela P. Norepinephrine drives persistent activity in prefrontal cortex via synergistic alpha1 and alpha2 adrenoceptors. PLoS One 2013, 8(6):e66122.
63. Shin L.M., Rauch S.L., Pitman R.K. Amygdala, medial prefrontal cortex, and hippocampal function in PTSD. Ann N Y Acad Sci 2006, 1071:67-79.
64. Glover D.A., Powers M.B., Bergman L., Smits J.A., Telch M.J., Stuber M. Urinary dopamine and turn bias in traumatized women with and without PTSD symptoms. Behav Brain Res 2003, 144(1-2):137-141.
65. DeBellis M.D., Baum A.S., Birmaher B., Keshavan M.S., Eccard C.H., Boring C.H., et al. A.E. Bennett Research Award. Developmental traumatology. Part I: Biological stress systems. Biol Psychiatry 1999, 45(10):1259-1270.
66. Butts K.A., Weinberg J., Young A.H., Phillips A.G. Glucocorticoid receptors in the prefrontal cortex regulate stress-evoked dopamine efflux and aspects of executive function. Proc Natl Acad Sci USA 2011, 108(45):18459-18464.
67. Tawa J., Murphy S. Psychopharmacological treatment for military posttraumatic stress disorder: an integrative review. J Am Assoc Nurse Pract 2013, 25(8):419-423.
68. Doogan D.P., Caillard V. Sertraline in the prevention of depression. Br J Psychiatry 1992, 160:217-222.
69. Miller I.W., Keitner G.I., Schatzberg A.F., Klein D.N., Thase M.E., Rush M.E., et al. The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine. J Clin Psychiatry 1998, 59(11):608-619.
70. Davidson J.R., Rothbaum B.O., van der Kolk B.A., Sikes C.R., Farfel G.M. Multicenter: double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry 2001, 58(5):485-492.